In an article published in Nature, Dr. Madelon Finkel weighed in on the challenges and innovations of detecting early signs of cancer among populations in low- and middle-income countries (LMICs). Compared to high-income countries, these populations face a lack of infrastructure, equipment and personnel. Even while new cancer screening is available in some countries and has been shown to significantly reduce mortality, participation is an issue until community health workers help facilitate trust. Further, when more screening does become available, the ethical dilemna of screening patients without sufficient resources for follow-up care remains. Read more here.